Eric Spyra has over 30 years of work experience in various roles within the finance and healthcare industries. Eric started their career as a Financial Consultant at Merrill Lynch in 1991 and later joined Svigos Asset Management, LLC as a Senior Managing Director from 1993 to 1998. In 1998, they became a Senior Asset Manager at Cire International, LLC.
In recent years, Eric has held leadership positions in healthcare companies. Eric served as the Chief Investment and Development Officer at Intellivisit from 2019 to 2020, where they helped develop a virtual care delivery platform. In 2020, they became the Chief Executive Officer of Endsulin, a company focused on innovative treatments for diabetes.
Eric has also been involved in investment activities. Since 2015, they have been the Lead Series-B Investor at American Gene Technologies International Inc., where they utilized their experience and industry contacts to secure funding for the company.
Throughout their career, Eric has demonstrated their expertise in finance and investment, as well as their commitment to advancing healthcare technologies and treatments.
Eric Spyra obtained a Bachelor of Science degree in Finance from Northern Illinois University, which they attended from 1987 to 1991.
Sign up to view 0 direct reports
Get started
This person is not in any offices